
欧洲生物制药管市场预测至 2028 年 - COVID-19 影响和按类型(塑料、金属和硅胶)和应用(制药、医疗器械、研发等)进行的区域分析
No. of Pages: 122 | Report Code: TIPRE00024063 | Category: Life Sciences
No. of Pages: 122 | Report Code: TIPRE00024063 | Category: Life Sciences
生物制药管材采用挤出工艺生产,广泛应用于药物输送系统、饲管等蠕动泵。这些产品具有卓越的热学、机械和化学特性,可用于各种微创应用,包括支架输送系统、心血管导管和泌尿外科检索设备。此外,这些还用于麻醉和呼吸设备、静脉注射和生物制药实验室设备。
欧洲生物制药管材市场预计将从2021年的8.2765亿美元增至2028年的14.7445亿美元;预计2021年至2028年复合年增长率为8.6%。市场的增长归因于一些关键驱动因素,例如世界老年人口的增加以及对微创手术的需求不断增长。然而,政府对生物制药应用的严格监管框架预计将限制预测期内的市场增长。
近年来,微创外科手术的受欢迎程度有所增加,原因是具有切口小、患者康复快、减少患者不适等优点。关节炎、癌症和心血管疾病的患病率不断上升,所有这些疾病都需要广泛的手术治疗,这增加了对微创手术的需求。因此,对导管和生物制药管材等组件的需求巨大。此外,生物制药管道系统价格合理,有助于节省时间。例如,使用导管进行心导管插入术和尿导管插入术可显着缩短医疗或外科手术所需的时间。因此,对微创医疗手术的需求不断增长以及对提高这些手术效率的关注在推动生物制药管材的需求方面发挥着重要作用。此外,越来越多地使用铂固化硅胶作为生物制药管的首选材料,与传统的过氧化物固化管相比,具有多种优势。例如,2020 年 1 月,沃森马洛流体技术集团 (WMFTG) 推出了 BioPure 硅胶传输管,为各种生物工艺流体传输应用提供安全、可靠且经济高效的解决方案。因此,在预测期内,铂固化硅胶管作为首选材料的推出和使用可能会成为生物制药市场的一个重要趋势。因此,市场参与者有巨大的机会以优质且具有成本效益的产品进入市场。
COVID-19 大流行严重影响了欧盟 (EU) 的工业。随着需要通气支持(高流量氧疗、无创通气、有创机械通气和体外膜肺氧合)的COVID-19患者数量增加,去年对医用管材的需求也有所增加。此外,患有哮喘和糖尿病等现有疾病的人中COVID-19感染的增加也影响了市场的增长,这反过来又推动了对鼻胃管、雾化器和储雾器等药物输送装置和设备的需求设备。此外,该国强大的工业基础和多家知名医疗管制造商的存在正在加强该国的市场增长。预计这些因素将在预测期内推动该地区对生物制药管材的需求。
根据类型,欧洲生物制药管道市场分为塑料、金属和硅胶。有机硅细分市场在 2021 年占据最大市场份额,预计在预测期内市场复合年增长率最高。
根据应用情况,欧洲生物制药管材市场细分为制药、医疗器械、研发等。制药领域在 2021 年占据了最大的市场份额,预计在预测期内将实现最高的复合年增长率。
p>
一些相关的主要和次要来源这份关于欧洲生物制药管材市场的报告包括欧盟 (EU)、英国心脏基金会 (BHF)、欧洲心脏病学会 (ESC) 和意大利统计研究所 (ISTAT)。
Strategic insights for Europe Biopharmaceutical Tubing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 827.65 Million |
Market Size by 2028 | US$ 1,474.45 Million |
Global CAGR (2021 - 2028) | 8.6% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Biopharmaceutical Tubing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Biopharmaceutical Tubing Market is valued at US$ 827.65 Million in 2021, it is projected to reach US$ 1,474.45 Million by 2028.
As per our report Europe Biopharmaceutical Tubing Market, the market size is valued at US$ 827.65 Million in 2021, projecting it to reach US$ 1,474.45 Million by 2028. This translates to a CAGR of approximately 8.6% during the forecast period.
The Europe Biopharmaceutical Tubing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Biopharmaceutical Tubing Market report:
The Europe Biopharmaceutical Tubing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Biopharmaceutical Tubing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Biopharmaceutical Tubing Market value chain can benefit from the information contained in a comprehensive market report.